DAM
BIIB icon

Deltec Asset Management’s Biogen BIIB Stock Holding History

Deltec Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-21,155
Closed -$6.48M – 146
2015
Q4 		$6.48M Sell
21,155
-7,350
-26% -$2.11M 1.65% 17
2015
Q3 		$8.32M Buy
28,505
+24,005
+533% +$7.93M 2.06% 11
2015
Q2 		$1.82M Buy
+4,500
New +$1.81M 0.4% 50

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Deltec Asset Management's BIIB Position: Q1 2016 in Review

Deltec Asset Management sold out of Biogen (BIIB) in Q1 2016, closing a stake of 21,155 shares — an estimated $6.48M sold.

Deltec Asset Management first reported a position in BIIB in Q2 2015 and held it in 3 quarters. The position peaked at $8.32M in Q3 2015. 948 funds tracked by Wall St. Rank hold BIIB as of Q1 2016.

  • Deltec Asset Management reported no remaining Biogen position as of Q1 2016 after selling out during the quarter.
  • Deltec Asset Management sold 21,155 Biogen shares in Q1 2016, an estimated $6.48M.
  • Deltec Asset Management first reported a position in Biogen in Q2 2015 and held it in 3 quarters.
  • Deltec Asset Management's Biogen position peaked at $8.32M in Q3 2015.
  • 948 funds tracked by Wall St. Rank held Biogen as of Q1 2016.

Based on Deltec Asset Management's 13F filing for Q1 2016, filed 27 Apr 2016.